205 related articles for article (PubMed ID: 27646763)
1. The absence of multiple atypical nevi in germline CDKN2A mutations: Comment on "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome".
Ipenburg NA; Gruis NA; Bergman W; van Kester MS
J Am Acad Dermatol; 2016 Oct; 75(4):e157. PubMed ID: 27646763
[No Abstract] [Full Text] [Related]
2. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.
Lynch HT; Brand RE; Hogg D; Deters CA; Fusaro RM; Lynch JF; Liu L; Knezetic J; Lassam NJ; Goggins M; Kern S
Cancer; 2002 Jan; 94(1):84-96. PubMed ID: 11815963
[TBL] [Abstract][Full Text] [Related]
3. Reply to: "The absence of multiple atypical nevi in germline CDKN2A mutations".
Soura E; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Oct; 75(4):e159. PubMed ID: 27646764
[No Abstract] [Full Text] [Related]
4. Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.
Rulyak SJ; Brentnall TA; Lynch HT; Austin MA
Cancer; 2003 Aug; 98(4):798-804. PubMed ID: 12910525
[TBL] [Abstract][Full Text] [Related]
5. The atypical-mole syndrome and predisposition to melanoma.
Wachsmuth RC; Harland M; Bishop JA
N Engl J Med; 1998 Jul; 339(5):348-9. PubMed ID: 9696648
[No Abstract] [Full Text] [Related]
6. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
Celebi JT; Ward KM; Wanner M; Polsky D; Kopf AW
Clin Exp Dermatol; 2005 Jan; 30(1):68-70. PubMed ID: 15663508
[TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; from p16 to melanoma].
Gruis NA; Bergman W
Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670
[TBL] [Abstract][Full Text] [Related]
8. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
[TBL] [Abstract][Full Text] [Related]
9. CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.
Dalmasso B; Pastorino L; Ciccarese G; Andreotti V; Grillo F; Mastracci L; Spagnolo F; Ballestrero A; Queirolo P; Bruno W; Ghiorzo P
J Am Acad Dermatol; 2019 May; 80(5):1263-1271. PubMed ID: 30274933
[TBL] [Abstract][Full Text] [Related]
10. [Familial malignant melanoma].
Ueda M
Nihon Rinsho; 2000 Jul; 58(7):1381-4. PubMed ID: 10921309
[TBL] [Abstract][Full Text] [Related]
11. From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients.
de Snoo FA; Kroon MW; Bergman W; ter Huurne JA; Houwing-Duistermaat JJ; van Mourik L; Snels DG; Breuning MH; Willemze R; Frants RR; Gruis NA
J Am Acad Dermatol; 2007 May; 56(5):748-52. PubMed ID: 17276542
[TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.
Bishop JA; Wachsmuth RC; Harland M; Bataille V; Pinney E; MacK P; Baglietto L; Cuzick J; Bishop DT
J Invest Dermatol; 2000 Jan; 114(1):28-33. PubMed ID: 10620111
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.
Potjer TP; van der Stoep N; Houwing-Duistermaat JJ; Konings IC; Aalfs CM; van den Akker PC; Ausems MG; Dommering CJ; van der Kolk LE; Maiburg MC; Spruijt L; Wagner A; Vasen HF; Hes FJ
BMC Res Notes; 2015 Jun; 8():264. PubMed ID: 26111702
[TBL] [Abstract][Full Text] [Related]
14. New developments in melanoma genetics.
Hayward N
Curr Oncol Rep; 2000 Jul; 2(4):300-6. PubMed ID: 11122857
[TBL] [Abstract][Full Text] [Related]
15. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
[TBL] [Abstract][Full Text] [Related]
16. Multiple primary melanoma revisited.
Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
[TBL] [Abstract][Full Text] [Related]
17. Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reports.
van der Wilk BJ; Noordman BJ; Atmodimedjo PN; Dinjens WNM; Laheij RJF; Wagner A; Wijnhoven BPL; van Lanschot JJB
Eur J Med Genet; 2020 Mar; 63(3):103840. PubMed ID: 31923587
[TBL] [Abstract][Full Text] [Related]
18. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):395-407; quiz 408-10. PubMed ID: 26892650
[TBL] [Abstract][Full Text] [Related]
19. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.
Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H
JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
de Snoo FA; Hottenga JJ; Gillanders EM; Sandkuijl LA; Jones MP; Bergman W; van der Drift C; van Leeuwen I; van Mourik L; Huurne JA; Frants RR; Willemze R; Breuning MH; Trent JM; Gruis NA
Eur J Hum Genet; 2008 Sep; 16(9):1135-41. PubMed ID: 18398432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
